Correlation Between Marizyme and Living Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Marizyme and Living Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marizyme and Living Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marizyme and Living Cell Technologies, you can compare the effects of market volatilities on Marizyme and Living Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marizyme with a short position of Living Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marizyme and Living Cell.

Diversification Opportunities for Marizyme and Living Cell

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Marizyme and Living is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Marizyme and Living Cell Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Living Cell Technologies and Marizyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marizyme are associated (or correlated) with Living Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Living Cell Technologies has no effect on the direction of Marizyme i.e., Marizyme and Living Cell go up and down completely randomly.

Pair Corralation between Marizyme and Living Cell

Given the investment horizon of 90 days Marizyme is expected to generate 2.69 times more return on investment than Living Cell. However, Marizyme is 2.69 times more volatile than Living Cell Technologies. It trades about 0.13 of its potential returns per unit of risk. Living Cell Technologies is currently generating about 0.13 per unit of risk. If you would invest  1.00  in Marizyme on December 27, 2024 and sell it today you would lose (0.19) from holding Marizyme or give up 19.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.41%
ValuesDaily Returns

Marizyme  vs.  Living Cell Technologies

 Performance 
       Timeline  
Marizyme 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Marizyme are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Marizyme displayed solid returns over the last few months and may actually be approaching a breakup point.
Living Cell Technologies 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Living Cell Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting essential indicators, Living Cell reported solid returns over the last few months and may actually be approaching a breakup point.

Marizyme and Living Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Marizyme and Living Cell

The main advantage of trading using opposite Marizyme and Living Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marizyme position performs unexpectedly, Living Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Living Cell will offset losses from the drop in Living Cell's long position.
The idea behind Marizyme and Living Cell Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas